These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8240556

  • 21. The influence of caffeine on the steady-state pharmacokinetics of theophylline.
    Jonkman JH, Sollie FA, Sauter R, Steinijans VW.
    Clin Pharmacol Ther; 1991 Mar; 49(3):248-55. PubMed ID: 2007319
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy.
    Chyka PA, Holley JE, Mandrell TD, Sugathan P.
    Ann Emerg Med; 1995 Mar; 25(3):356-62. PubMed ID: 7864477
    [Abstract] [Full Text] [Related]

  • 25. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA, Henry JA.
    J Toxicol Clin Toxicol; 1995 Mar; 33(1):43-9. PubMed ID: 7837312
    [Abstract] [Full Text] [Related]

  • 26. Activated charcoal in theophylline intoxication.
    Brashear RE, Aronoff GR, Brier RA.
    J Lab Clin Med; 1985 Sep; 106(3):242-5. PubMed ID: 4031629
    [Abstract] [Full Text] [Related]

  • 27. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
    Gomez HF, McClafferty HH, Flory D, Brent J, Dart RC.
    Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
    [Abstract] [Full Text] [Related]

  • 28. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA, Glucksman E, Henry JA.
    Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441
    [Abstract] [Full Text] [Related]

  • 29. Enhancement of theophylline clearance by oral activated charcoal.
    Berlinger WG, Spector R, Goldberg MJ, Johnson GF, Quee CK, Berg MJ.
    Clin Pharmacol Ther; 1983 Mar; 33(3):351-4. PubMed ID: 6337763
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The influence of intravenous cimetidine dosage regimens on the disposition of theophylline.
    Gutfeld MB, Welage LS, Walawander CA, Wilton JH, Harrison NJ.
    J Clin Pharmacol; 1989 Jul; 29(7):665-9. PubMed ID: 2760260
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.
    Orisakwe OE, Ilondu NA, Afonne OJ, Ofoefule SI, Orish CN.
    Pharmacol Res; 2000 Aug; 42(2):167-70. PubMed ID: 10887047
    [Abstract] [Full Text] [Related]

  • 36. Effect of Activated Charcoal on Rivaroxaban Complex Absorption.
    Ollier E, Hodin S, Lanoiselée J, Escal J, Accassat S, De Magalhaes E, Basset T, Bertoletti L, Mismetti P, Delavenne X.
    Clin Pharmacokinet; 2017 Jul; 56(7):793-801. PubMed ID: 27910037
    [Abstract] [Full Text] [Related]

  • 37. Cimetidine-theophylline interaction: effects of age and cimetidine dose.
    Cohen IA, Johnson CE, Berardi RR, Hyneck ML, Achem SR.
    Ther Drug Monit; 1985 Jul; 7(4):426-34. PubMed ID: 4082242
    [Abstract] [Full Text] [Related]

  • 38. Prolonged toxicity following massive ingestion of sustained-release theophylline preparation.
    Corser BC, Youngs C, Baughman RP.
    Chest; 1985 Nov; 88(5):749-50. PubMed ID: 4053717
    [Abstract] [Full Text] [Related]

  • 39. Increased serum theophylline clearance with orally administered activated charcoal.
    Byatt CM, Henry JA.
    Am Rev Respir Dis; 1984 Jul; 130(1):147-8. PubMed ID: 6742605
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.